These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 11337365)
1. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Lüttges J; Galehdari H; Bröcker V; Schwarte-Waldhoff I; Henne-Bruns D; Klöppel G; Schmiegel W; Hahn SA Am J Pathol; 2001 May; 158(5):1677-83. PubMed ID: 11337365 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
3. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385 [TBL] [Abstract][Full Text] [Related]
7. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation. Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137 [TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318 [TBL] [Abstract][Full Text] [Related]
9. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of Smad4 in gastric carcinomas. Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080 [TBL] [Abstract][Full Text] [Related]
11. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454 [TBL] [Abstract][Full Text] [Related]
12. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877 [TBL] [Abstract][Full Text] [Related]
13. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis. Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801 [TBL] [Abstract][Full Text] [Related]
14. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
15. DPC4 gene in various tumor types. Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691 [TBL] [Abstract][Full Text] [Related]
16. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913 [TBL] [Abstract][Full Text] [Related]
17. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC. Lassus H; Salovaara R; Aaltonen LA; Butzow R Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451 [TBL] [Abstract][Full Text] [Related]
18. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Bläker H; von Herbay A; Penzel R; Gross S; Otto HF Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187 [TBL] [Abstract][Full Text] [Related]
19. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination. Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524 [TBL] [Abstract][Full Text] [Related]
20. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers. Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]